Garner Health vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 53)
Garner Health logo

Garner Health

ChallengerHealthcare

Employer Health Benefits & Care Navigation

Garner Health uses the largest US claims database (60B+ records) and 700-metric algorithms to steer employees to top-performing doctors, delivering avg. 12% employer cost savings and 80% lower employee out-of-pocket costs.

AI VisibilityBeta
Overall Score
C53
Category Rank
#239 of 596
AI Consensus
81%
Trend
stable
Per Platform
ChatGPT
50
Perplexity
48
Gemini
53

About

Garner Health is a care navigation company that uses advanced data analytics to connect employers and their employees with the highest-quality, most cost-effective physicians in their area. Founded in New York, Garner has assembled the largest medical claims database in the United States — containing over 60 billion records from 320 million patients — and built a proprietary algorithm that ranks physicians across 700 outcome and cost metrics. Employers integrate Garner into their health plan design, and employees receive financial incentives to choose Garner-recommended providers, typically paying 80% less out-of-pocket.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

53
Overall Score
93
#239
Category Rank
#1
81
AI Consensus
80
stable
Trend
stable
50
ChatGPT
94
48
Perplexity
89
53
Gemini
94
48
Claude
92
55
Grok
98

Key Details

Category
Employer Health Benefits & Care Navigation
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.